Literature DB >> 11310460

A comparison of intramuscular ketamine with high dose intramuscular midazolam with and without intranasal flumazenil in children before suturing.

R McGlone1, T Fleet, S Durham, S Hollis.   

Abstract

OBJECTIVES: (a) To compare the use of high dose intramuscular midazolam with and without intranasal flumazenil in children after suturing. (b) To compare the use of high dose intramuscular midazolam with low dose intramuscular ketamine in children before suturing.
METHODS: 87 children, aged between 1 and 7 years, presenting with simple wounds needing sedation, were studied. Children considered combative (n=47) were given ketamine (2.5 mg/kg intramuscularly). The remaining 40 children were given midazolam (0.4 mg/kg intramuscularly) with and without flumazenil (25 microg/kg, intranasally).
RESULTS: The median oxygen saturation was 97% in both midazolam groups. Flumazenil significantly reduced the amount of agitation during recovery (p=0.048) and also the time at which children were ready for discharge (median 55 versus 95 minutes, p value <0.001). After discharge both midazolam groups had an unsteady gait (75%) and there was no significant difference in the duration. As expected because of the deliberate selection of combative children into the ketamine group, the pre-sedation behaviour was slightly more disturbed compared with the midazolam group (p=0.10). However, the ketamine group was less agitated during local anaesthetic and suturing p<0.001.
CONCLUSION: Intramuscular midazolam (0.4 mg/kg) did not effectively sedate the children, in that a significant number still had to be restrained. However, none could remember the suturing. Intranasal flumazenil seems to be effective in shortening the time to discharge. If midazolam is to be used then a dose high enough to produce full amnesia should be used, there seems to be no advantage in increasing the dose further. Low dose intramuscular ketamine remains the drug of choice.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11310460      PMCID: PMC1725512          DOI: 10.1136/emj.18.1.34

Source DB:  PubMed          Journal:  Emerg Med J        ISSN: 1472-0205            Impact factor:   2.740


  18 in total

1.  Intranasal midazolam as a sedative for children during laceration repair.

Authors:  D M Yealy; J H Ellis; G D Hobbs; R M Moscati
Journal:  Am J Emerg Med       Date:  1992-11       Impact factor: 2.469

2.  Pharmacokinetics of midazolam in children: comparative study of intranasal and intravenous administration.

Authors:  E Rey; L Delaunay; G Pons; I Murat; M O Richard; C Saint-Maurice; G Olive
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

3.  Ketamine sedation for pediatric procedures: Part 1, A prospective series.

Authors:  S M Green; R Nakamura; N E Johnson
Journal:  Ann Emerg Med       Date:  1990-09       Impact factor: 5.721

Review 4.  The use of flumazenil in the management of acute drug poisoning--a review.

Authors:  A Weinbroum; P Halpern; E Geller
Journal:  Intensive Care Med       Date:  1991       Impact factor: 17.440

5.  Complication of intranasal midazolam.

Authors:  R A Lugo; M Fishbein; M C Nahata; B Lininger
Journal:  Pediatrics       Date:  1993-10       Impact factor: 7.124

6.  Antagonism of the hypnotic effect of midazolam in children: a randomized, double-blind study of placebo and flumazenil administered after midazolam-induced anaesthesia.

Authors:  R D Jones; A D Lawson; L J Andrew; W M Gunawardene; J Bacon-Shone
Journal:  Br J Anaesth       Date:  1991-06       Impact factor: 9.166

7.  The pharmacokinetics of midazolam in paediatric patients.

Authors:  K Payne; F J Mattheyse; D Liebenberg; T Dawes
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

8.  Nasal versus oral midazolam for sedation of anxious children undergoing laceration repair.

Authors:  K Connors; T E Terndrup
Journal:  Ann Emerg Med       Date:  1994-12       Impact factor: 5.721

9.  Pharmacokinetics of flumazenil and midazolam.

Authors:  R D Jones; K Chan; C J Roulson; A G Brown; I D Smith; G H Mya
Journal:  Br J Anaesth       Date:  1993-03       Impact factor: 9.166

10.  Intramuscular midazolam premedication in small children. A comparison with papaveretum and hyoscine.

Authors:  M B Taylor; P R Vine; D J Hatch
Journal:  Anaesthesia       Date:  1986-01       Impact factor: 6.955

View more
  3 in total

1.  Predictors of emesis in children undergoing procedural sedation with intramuscular ketamine in a paediatric emergency department.

Authors:  Shruthi Suryaprakash; Lai Peng Tham
Journal:  Singapore Med J       Date:  2016-12-09       Impact factor: 1.858

Review 2.  Ketamine for paediatric sedation/analgesia in the emergency department.

Authors:  M C Howes
Journal:  Emerg Med J       Date:  2004-05       Impact factor: 2.740

3.  The Lancaster experience of 2.0 to 2.5 mg/kg intramuscular ketamine for paediatric sedation: 501 cases and analysis.

Authors:  R G McGlone; M C Howes; M Joshi
Journal:  Emerg Med J       Date:  2004-05       Impact factor: 2.740

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.